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Strategies to enhance the capacity of grafted stem/progenitors cells to generate multipotential, proliferative
and migrating pools of cells in the postnatal brain could be crucial for structural repair after brain damage.
We investigated whether the over-expression of basic fibroblast growth factor 2 (FGF-2) in neural progenitor
cells (NPCs) could provide a robust source of migrating NPCs for tissue repair in the rat cerebral cortex.
Using live imaging we provide direct evidence that FGF-2 over-expression significantly enhances the migratory
capacity of grafted NPCs in complex 3D structures, such as cortical slices. Furthermore, we show that the
migratory as well as proliferative properties of FGF-2 over-expressing NPCs are maintained after in vivo trans-
plantation. Importantly, after transplantation into a neonatal ischaemic cortex, FGF-2 over-expressing NPCs
efficiently invade the injured cortex and generate an increased pool of immature neurons available for brain
repair. Differentiation of progenitor cells into immature neurons was correlated with a gradual down-regulation
of the FGF-2 transgene. These results reveal an important role for FGF-2 in regulating NPCs functions when
interacting with the host tissue and offer a potential strategy to generate a robust source of migrating and
immature progenitors for repairing a neonatal ischaemic cortex.
Keywords: Brain repair; neonatal ischemia; neural progenitors; transplantation; migration; FGF-2
Abbreviations: DCX=doublecortin; DIV=days in vitro; GABA=(g-aminobutyric acid; GAD-67=glutamic acid decarboxy-
lase 67; NPCs=neural progenitor cells; SVZ=subventricular zone; TU=transducing units
Received May17, 2007. Revised July 20, 2007. Accepted August 2, 2007. Advance Access publication August 29, 2007
Introduction
The postnatal cortex has a very limited ability to regenerate
neural tissue after brain insults. This is due in part to the
lack of a resident population of neural progenitor cells
(NPCs) responsive to signals derived from the damaged
tissue. Compensatory cortical neurogenesis has been
reported after induced apoptotic degeneration (Magavi
et al., 2000) or after stroke (Jiang et al., 2001; Jin et al.,
2003), but the number of newly generated neurons, if
present at all (Arvidsson et al., 2002), remains insufficient
to restore a normal cortical function (Bjorklund and
Lindvall, 2000). To overcome this limitation, the
manipulation of NPCs has developed into a key strategy
for brain repair. Attempts have been made to stimulate the
postnatal subventricular zone (SVZ) with growth hormones
in order to recruit a population of NPCs towards the
lesioned cortex. These approaches have been supported by
the finding that growth hormones such as the basic
fibroblast growth factor (FGF-2) are capable of increasing
the proliferation of SVZ progenitors and promote olfactory
bulb neurogenesis (Kuhn et al., 1997). Furthermore,
chronic infusion of FGF-2 and the epidermal growth
factor in the lateral ventricles has been shown to be critical
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in regenerating new hippocampal neurons after global
ischaemia (Nakatomi et al., 2002). However, successful
replacement of damaged cortical neurons using NPCs has
not been reported. Among the multiple factors limiting the
efficiency of NPC transplantation in the postnatal cortex is
the fact that grafted NPCs rapidly lose their immature,
proliferative and migratory properties. It would therefore
be of considerable interest to supply a source population of
multipotential, proliferative and migrating NPCs competent
to respond to chemoattractant cues secreted by the site of
injury. Support for this hypothesis derives from in vitro
work showing that FGF-2-stimulated NPCs can respond to
a chemoattractant cue such as vascular endothelial growth
factor (Zhang et al., 2003).
Autocrine/paracrine signalling of FGF-2 appears to play a
key role in sustaining self-renewal of neural progenitor/stem
cells in vitro (Maric et al., 2003) and maintaining immature
proliferative populations in neurogenic niches in vivo
(Zheng et al., 2004). We therefore tested the hypothesis
that over-expression of FGF-2 in transplanted NPCs may
provide robust sources of migrating NPCs for tissue repair
after brain damage.
Materials and methods
All animal experiments were conducted in accordance with
Swiss laws, previously approved by the Geneva Cantonal
Veterinary Authority.
Isolation, cultures and differentiation of
NPCs in vitro
The SVZ from coronal slices of newborn rat brains were
dissected, mechanically dissociated and trypsinized. NPCs were
purified using a 22% Percoll gradient centrifugation as previously
described (Lim et al., 2000; Zhang et al., 2003) and seeded at
4 105 cells/dish concentration onto matrigel-coated dishes
(1:500). Cells were allowed to expand in neurobasal medium
(Invitrogen) supplemented with 20 ng/ml FGF-2 (human recom-
binant, R&D), 2% B27 supplement (Invitrogen), 2 mM
L-glutamine, 1 mM sodium pyruvate, 2 mM N-acetyl-cysteine
and 1% penicillin–streptomycin. At DIV3, half of the medium
was replaced with fresh medium containing 20 ng/ml of FGF-2
with either the control lentiviral vector or FGF-2 lentiviral vector.
For FGF-2 deprivation experiments, the dishes were washed and
2 ml of fresh medium was added with or without FGF-2
(20 ng/ml). To induce differentiation, NPCs were trypsinized at
DIV5, seeded at 5 104 cells/dish concentration onto matrigel-
coated dishes (1:500), allowed to expand during 48 h in the
presence of 20 ng/ml FGF-2. Differentiation was induced by
removing FGF-2 and adding 20 ng/ml BDNF and 1% fetal calf
serum (Invitrogen).
Design and production of lentiviral vectors
The pWPI_SPbFGF lentiviral vector coding for FGF-2 was
constructed as follows. A cDNA coding for the 18 kDa form of
the human FGF-2 (basic FGF) fused to an immunoglobulin signal
peptide facilitating the secretion of FGF-2 (Rinsch et al., 2001) was
cloned into the pWPI bicistronic lentiviral vector. pWPI is an
HIV-1 derived SIN vector containing the EF1 alpha promoter and
an EMCV-IRES-GFP cistron (http://tronolab.epfl.ch/). FGF-2 was
cloned in the PmeI site located between the EF1 alpha promoter
and the IRES_GFP sequences. Control lentiviral vectors were the
following: pFUGW contains the ubiquitin promoter controlling
the expression of GFP, pWPXL contains the EF1 alpha promoter
controlling the expression of GFP (http://tronolab.epfl.ch/) and
RIX-PGK-Tom-W vector was constructed by inserting the
tdTomato gene (Shaner et al., 2004) downstream of the hPGK
promoter, in place of the GFP gene of the RIX-PGK-GFP-W
vector. EF1 alpha, ubiquitin and PGK promoters are ubiquitous
and active in neural cells. Details on pWPI plasmid and on
the RIX-PGK-Tom-W vector can be obtained at http://www.
medecine.unige.ch/salmon/.
Lentiviral vectors were produced, concentrated and titrated
according to standard protocols. Details on procedures can be
obtained at http://www.medecine.unige.ch/salmon/. Control and
FGF-2 lentiviral vectors had titers ranging from 108 to 109
transducing units (TU)/ml. Transduction of NPCs was done at
DIV3 except at DIV2 for the BrdU deprivation study. NPCs
(50 000–75 000 cells per 35 mm culture dish) were transduced
using doses ranging from 5 104 to 5 105 TU of either control
or FGF-2 lentiviral vectors.
FGF-2 secretion in the medium
To measure the secretion of FGF-2 by NPCs, cultures were
transduced at DIV3 with the GFP control lentiviral vector and the
FGF-2 lentiviral vector (1.5 105 TU/ml). At DIV6, cultures were
washed with fresh medium containing no FGF-2. At DIV8, the
medium was removed and the amount of FGF-2 secreted in the
medium was quantified using a standard ELISA detection method
(Quantikine, R&D). Cells were trypsinized, counted and the
percentage of GFP positive cells was analysed by FACS.
Tissue processing and immunohistochemistry
Cultures and cortical slices were fixed overnight at 4C with cold
4% paraformaldehyde (PFA) (pH 7.4). Rats were anesthesized by
pentobarbital and sacrificed by intra-cardial perfusion of 0.9%
saline followed by 4% PFA (pH 7.4). Brains were extracted from
the skull and post-fixed in 4% PFA (pH 7.4) at 4C overnight and
cryoprotected with sucrose 30% if cut on a cryostat. For histology
processing, 20 mm thick sections were cut on a cryostat or 60 mm
thick sections were cut on a Vibratome 1500; sections or slices
were washed three times with 0.1 M (PBS); incubated overnight at
4C with a primary antibody diluted in PBS/0.5% bovine serum
albumine (BSA)/0.3% Triton X-100; washed in PBS; incubated
with the secondary antibodies against the appropriate species;
nuclear counterstained with 33 258 bisbenzimide (Invitrogen) or
TO-PRO-3 (Invitrogen). The following primary antibodies were
used: monoclonal mouse anti-FGF-2 (1:250; Upstate), monoclonal
mouse anti-nestin (1:1000, Chemicon), polyclonal rabbit anti-
NCAM (1:1000) (Zhang et al., 2003), polyclonal rabbit anti-
NG2 (1:250; Chemicon), polyclonal rabbit anti-GFAP (1:500;
Dakopatts), polyclonal goat anti-doublecortin (1:100; Santa Cruz),
monoclonal mouse anti-GAD67 (1:1000; Chemicon), polyclonal
rabbit anti-GFP (1:1000; Molecular Probes, Invitrogen),
monoclonal mouse anti-NeuN (1:250; Chemicon), monoclonal
mouse anti-BrdU (1:100; Boehringer-Mannheim), monoclonal
rat anti-BrdU (1:100; Oxford Biotech. Ltd.), polyclonal rabbit
anti-calretinin (1:1000; Swant, Switzerland), monoclonal mouse
Expression of FGF-2 in neural progenitors Brain (2007), 130, 2962^2976 2963
anti-calbindin (1:5000; Swant, Switzerland), goat anti-parvalbumin
(1:5000; Swant, Switzerland), mouse anti-FGFR1(1:100; Upstate),
rabbit anti-FGFR2 (SC-122) (1:100; Santa-Cruz). The following
secondary antibodies were used: anti-rabbit Alexa-568 and Alexa-
488, anti-mouse Alexa-488 and Alexa-568, anti-goat Alexa-555
and Alexa-647 (Invitrogen). For BrdU labelling, cultures and
cortical slices were incubated 30 min in 2 N HCL for DNA
denaturation followed by standard incubation.
BrdU incorporation experiments
For culture experiments, NPCs were expanded in FGF-2 (20 ng/ml)
during two days. At DIV2, the medium was removed and replaced by
(i) medium supplemented with FGF-2 (20 ng/ml) and containing
control lentiviral vector (1.5 105 TU/ml) (ii) medium containing
control lentiviral vector (1.5 105 TU/ml) without exogenous FGF-2
(iii) medium containing the FGF-2 lentiviral vector at two
different doses (0.75 105 TU/ml and 1.5 105 TU/ml) without
exogenous FGF-2. At DIV6, BrdU (10 mM) was added to the
medium during 16 h before PFA fixation. For BrdU incorpora-
tion experiments on cortical slices, BrdU (10 mM) was added to
the medium during 6 h before PFA fixation either at DIV1 or at
DIV2 after NPC deposition. For in vivo experiments, intra-
peritoneal BrdU (50 mg/kg) was injected twice daily from P7 to
P9 or from P37 to P39.
Cortical slice preparation and in vitro NPC
transplantation
The brains of P0 Sprague Dawley pups were dissected; 200 mm
coronal sections were cut on a Vibratome in ice-cold Hanks
medium and cultured on porous nitrocellulose filters (Millicell-
CM); Details for cortical slice cultures and in vitro NPC
transplantation can be found in the Supplementary Material. For
time-lapse imaging slices were placed in a microscope chamber
maintained at 37 and 5% CO2. For ex–in vivo slices, rats were
sacrificed at P5 after in vivo transplantation at P3 and slices were
cut as described above.
In vivo NPC transplantation
For in vivo transplantation in the intact cortex, Wistar pups at
postnatal day 3 (P3) were anesthetized with a mixture of Isofluran
(Foren 100%), O2 30% and air 70%, and maintained in a
stereotaxic frame. Hypoxia-ischaemia injury was performed at P3
as described previously (Sizonenko et al., 2003). Details on the
number of animals and the survival time points can be found
in the Supplementary Material.
Image processing
Epifluorescent time-lapse images were acquired with a digital
camera (Retiga EX; Qimaging) linked to a fluorescent microscope
(Eclipse TE2000-U; Nikon Corp.) equipped with Nikon Plan Fluor
4/0.13, 10/0.30 objectives and Nikon Plan Apo 60 A/1.40/oil
objective. Time-lapse images were quantified with the Openlab
software (version 3.1.2) and post hoc images were transferred to
image J (NIH) software for quantification. Confocal images
were acquired with a LSM 510 confocal microscope using a
Plan-Neofluar 40/1.3 oil objective. Unpaired t-test and w2 test
were performed using the software SigmaStat 3.1. Details on
quantification of cells can be obtained in the Supplementary
Material.
Results
Effects of FGF-2 over-expression on NPCs
in culture
To study the effects of FGF-2 over-expression in multi-
potential NPCs, SVZ cells were isolated from newborn rats
and expanded as described previously (Zhang et al., 2003).
Cultures were transduced after 3 days in vitro (DIV3) with
either the control green fluorescent protein (GFP) lentiviral
vector or the FGF-2-GFP lentiviral vector. At DIV6,
moderate FGF-2 immunoreactivity was detected in control
NPCs whereas a much stronger signal was detected in
FGF-2-transduced NPCs, showing that FGF-2 transduction
can efficiently increase FGF-2 expression (Fig. 1A). Elisa
quantification demonstrated that FGF-2 transduction
increased the amount of FGF-2 into the culture media by
10-fold (Fig. 1B). Control and FGF-2-transduced NPCs
expressed the FGF receptor 1 (FGFR1) and the FGF
receptor 2 (FGFR2) at the mRNA level and protein level
(Supplementary Fig. 1), demonstrating that NPCs could
bind secreted FGF-2. Quantification of the mRNA levels
using real-time PCR revealed that FGFR1 and FGFR2
mRNA levels were not significantly modified after FGF-2
transduction (Supplementary Fig. 1). To investigate if
FGF-2 over-expression could modify proliferation, cultures
were exposed to the S-phase marker bromodeoxyuridine
(BrdU) at DIV6. Proliferation significantly decreased in
cultures deprived of FGF-2, but could be restored after
FGF-2 transduction in a dose-dependent manner (Fig. 1C
and D). Taken together, these experiments demonstrate that
the FGF-2 transduction of NPCs increases the secretion
of FGF-2 and maintains the proliferation of NPCs in the
absence of exogenous FGF-2.
To study in vitro the effects of FGF-2 over-expression
in NPCs undergoing differentiation, we applied a protocol
that has been shown to induce neurogenesis (Zhang et al.,
2003). After 6 days of differentiation, we observed that
FGF-2-transduced cells had a strikingly different morphol-
ogy compared to control cells: the vast majority of FGF-
2-transduced cells displayed elongated processes strongly
immunoreactive for nestin and a cell body faintly GFAP
positive, whereas a high proportion of control cells dis-
played a much larger cell body strongly positive for GFAP
and variable levels of nestin immunoreactivity (Fig. 1E, F
and H). Furthermore, a significantly higher proportion of
control cells expressed the immature neuronal marker
doublecortin compared to FGF-2-transduced cells, indicat-
ing that FGF-2 transduction maintained the cells in an
undifferentiated phenotype (Fig. 1H). Only a small fraction
of cells expressed the oligodendrocyte precursor marker
NG2 in both conditions (Fig. 1H). FGF-2 immunohisto-
chemistry revealed a robust expression of FGF-2 in the
cytoplasm and nucleus of almost all FGF-2-transduced
NPCs, whereas FGF-2 immunoreactivity was located only
in a fraction of control NPCs (Fig. 1G and H). These
experiments indicate that in vitro FGF-2 over-expression
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can efficiently maintain NPCs in an immature state and
prevent them from undergoing differentiation.
FGF-2 over-expression promotes the
proliferation and migration of transplanted
NPCs on brain slices
To explore the behaviour of control and FGF-2-transduced
NPCs in a complex environment such as brain tissue,
we deposited small islets of NPCs on the surface of sub-
acute cortical slices (Fig. 2A). Twenty-four hours after
transplantation, FGF-2 transduction significantly increased
the size of transplanted islets compared to controls
(Fig. 2D). A combination of both proliferation and
migration could explain this increase. To investigate these
possibilities, BrdU pulse labelling was performed and
revealed a significantly higher proliferation rate in FGF-
2-transduced NPCs compared to control cells (Fig. 2B and
Fig. 1 FGF-2 transduction of neural progenitor cells (NPCs) maintains a pool of proliferative and immature cells in vitro. (A) Confocal
images showing FGF-2-transduced NPCs displaying an intense FGF-2 cytoplasmic immunoreactivity compared to control NPCs.
(B) Elisa quantification demonstrating a significant increase in the amount of secreted FGF-2 after FGF-2 transduction compared to control
transduction (P_0.05, t-test). (C) Dose-dependent increase in BrdU incorporation after FGF-2 transduction compared to control
transduction. After transduction at DIV2, NPCs were either maintained in 20ng/ml FGF-2 or deprived of exogenous FGF-2 (CTRL+FGF-2
deprived and FGF-2 vector). BrdU incorporation was performed at DIV6 (P_0.05,OneWay ANOVA). (D) Confocal images showing that
in the presence of exogenous FGF-2 (20ng/ml), a large fraction of control NPCs co-localize for BrdU. After 4 days of FGF-2 deprivation,
few control NPCs co-localize for BrdU whereas FGF-2 transduction increases the amount of NPCs co-localizing for BrdU. (E and F)
Confocal image showing that 6 days after induction of differentiation, a large fraction of control NPCs have differentiated into strongly
GFAP positive astrocytes displaying variable levels of nestin immunoreactivity (left panel). In contrast, FGF-2-transduced NPCs display
low levels of GFAP immunoreactivity and strong nestin immunoreactivity (right panel). (G) Confocal image showing that after induction
of differentiation a fraction of cells do not display FGF-2 immunoreactivity (arrow-head) whereas FGF-2-transduced NPCs are strongly
immunoreactive for FGF-2. (H) After 6 days of differentiation, the percentage of doublecortin positive neurons and strongly GFAP
positive astrocytes increase in the control condition whereas the vast majority of FGF-2-transduced NPCs remain immature and
express FGF-2 immunoreactivity (P_0.05, t-test). CTRL=control GFP-vector transduction at a dose of 1.5105TU/ml, FGF-2 vector
(0.75)=FGF-2-GFP vector transduction at a dose of 0.75105TU/ml, FGF vector (1.5)=FGF-2-GFP vector transduction at a dose
of 1.5105TU/ml. Scale bar=20mm.
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E). Furthermore, live-imaging of transplanted cells revealed
that FGF-2 transduction induced a significant shift in the
migration velocity (distance traveled per hour) of FGF-
2-transduced NPCs compared to controls (Fig. 2F).
To explore whether this pool of FGF-2-transduced NPCs
displayed enhanced invasive capacities, cortical slices were
fixed at DIV2 and analysed with a confocal microscope
(Fig. 3). Z-sectioning revealed a significant shift in the
depth migration between the two populations indicating
that FGF-2 transduction enables NPCs to invade more
efficiently cortical slices. These results indicate that FGF-2
lentiviral transduction not only maintains a pool of
immature proliferative NPCs but also promotes migratory
properties and enhances the invasion of cortical tissue.
Transplantation of FGF-2-transduced
NPCs in vivo
To further assess the effects of FGF-2 over-expression,
NPCs were transplanted in the cortex of postnatal day 3
(P3) pups. Two days later, animals were sacrificed and
cortical slices were prepared. Comparison of images taken
at DIV0 and DIV2 in both conditions revealed that FGF-
2-transduced NPCs could efficiently disperse in the
surrounding cortical tissue whereas the majority of control
NPCs remained near the locus of transplantation (Fig. 4A).
Time-lapse recordings done over a period of 12 h revealed
that control cells displayed limited migratory capacities.
(Fig. 4B, F1, Supplementary movie 1). In contrast, the
majority of FGF-2-transduced NPCs displayed a robust
migratory activity over the 12 h of time-lapse recordings.
(Fig. 4C, F2, Supplementary movie 2). Single cell tracking
analysis revealed that NPCs adopted a migratory strategy
characterized by the dynamic extension and retraction of
several processes allowing cells to switch from a bipolar
morphology with a leading process exhibiting lamellipodia
activity to a transient multipolar morphology (Fig. 4C,
Supplementary movie 2). Time-lapse recordings at DIV1
revealed a significant shift in the migration velocity of
control versus FGF-2-transduced NPCs (Fig. 4E).
Furthermore, we observed that a small fraction (1.66%)
of FGF-2-transduced cells divided en route after an initial
phase of migration, whereas this phenomenon was less
frequent (0.33%) in the control situation (Fig. 4C).
To explore the long-term effects of FGF-2 over-
expression on the dispersion of grafted NPCs, we
Fig. 1 Continued.
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transplanted control versus FGF-2-transduced NPCs in the
cortex of rat pups and analysed their brains at several
survival time points. Two weeks after transplantation, FGF-
2-transduced cells were found at increasing distances from
the center of the cortical transplantation site compared to
control cells (Fig. 5A and B). To know if the local secretion
of FGF-2 by FGF-2-transduced NPCs could be sufficient
to increase the dispersion of co-transplanted control NPCs,
we transplanted a mixture of the same amount of control
tomato-labelled NPCs and FGF-2-GFP-transduced NPCs
in the cortex of neonatal rats. Analysis of brains 8 days
after transplantation revealed that a significant proportion
of GFP-FGF-2-transduced cells had dispersed in the
surrounding cortex, whereas co-transplanted tomato-
labelled cells mainly remained at the locus of transplanta-
tion, indicating that FGF-2-transduction did not signifi-
cantly modify the behaviour of co-transplanted control
NPCs (Fig. 5C and D).
To investigate whether the increased dispersion of
FGF-2-transduced NPCs was linked to a change in their
proliferation index, BrdU labelling was performed between
P6 and P9 and animals were sacrificed at P10. Interestingly,
Fig. 2 FGF-2 transduction maintains a pool of proliferative andmigrating NPCs after transplantation on cortical slices. (A) Epifluorescence
images showing a larger increase in the size of a FGF-2-transduced GFP positive islet between DIV0 and DIV1 compared to a control islet.
(B) Confocal images showing that at DIV1 the proportion of GFP+cells co-localizing for BrdU (arrow-heads) is higher after FGF-2
transduction compared to the control condition. (C) Confocal images showing that at DIV2 the majority of control and FGF-2-transduced
NPCs express nestin, a marker of immature neural progenitors. (D) Graph showing that between DIV0 and DIV1, the mean radius
difference of FGF-2-transduced islets is increased compared to controls (P_0.001, t-test). (E) Graph showing that the BrdU proliferation
rate of FGF-2-transduced NPCs is increased at DIV1 and DIV2 compared to controls (P_0.001, Mann-Whitney). (F) Graph showing
a shift in the migration speed of FGF-2-transduced NPCs compared to controls (P_0.001, Chi-square test). CTRL=control GFP-vector
transduction, FGF vector=FGF-2-GFP vector transduction. Scale bar=100mm in A and 20mm in B and C.
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at this time point a significantly higher proportion of
FGF-2-transduced NPCs had incorporated BrdU compared
to controls (Fig. 5E and G). To explore if the phenotype of
transplanted NPCs was modified by FGF-2 transduction,
nestin staining was performed 2 weeks after transplantation
and revealed that a significant proportion of FGF-2-
transduced cells remained nestin positive whereas very few
control cells expressed this immature neural marker
(Fig. 5F and G). In contrast, staining for NG2, a marker
for oligodendrocyte precursors but also endothelial cells,
revealed that the majority of control cells expressed NG2
compared to only a small amount of FGF-2-transduced
cells. Staining for neuronal markers such as doublecortin
and NeuN revealed that only a very limited number
of control or FGF-2-transduced NPCs (50.5%) differ-
entiated into immature or mature neurons after trans-
plantation in the normal cortex. These results indicate
that FGF-2-transduction of NPCs increases their cortical
invasiveness in vivo and that this phenomenon is asso-
ciated with the preservation of an immature and prolifera-
tive state.
Constitutive FGF-2 over-expression in NPCs raises the
concern of potential tumour formation. To evaluate the
fate of FGF-2-transduced NPCs at longer survival time
points, we sacrificed rats 40 days after transplantation in the
intact cortex. At this time point, grafted FGF-2-transduced
NPCs were still more dispersed than control cells and no
tumour formation was detected. Immunohistochemistry
quantification revealed that the majority of GFP positive
cells had differentiated into NG2 positive cells (73.3 3.4%
mean SEM) or GFAP positive astroctyes (5.1 1.0%
mean SEM). Only a very small fraction of grafted NPCs
maintained an immature nestin phenotype (0.7 0.3%
mean SEM). To confirm that grafted cells had lost their
proliferative properties, BrdU injections were performed
three days before sacrifice. Only 2.7 0.8% (mean SEM)
of FGF-2-transduced cells still incorporated BrdU.
To investigate if the transient proliferative and migratory
properties of FGF-2-transduced cells could be correlated
with a change in the levels of FGF-2 production, we tracked
FGF-2 protein expression at different survival time points
after transplantation. We observed that at the early survival
time points during which FGF-2-transduced NPCs dis-
played proliferative and migratory properties, the majority
of FGF-2-transduced NPCs were strongly immunoreactive
for FGF-2, whereas at longer survival time points this
Fig. 3 FGF-2 transduction increases the invasiveness of NPCs in cortical slices.(A) Confocal Z-stacks at 5mm interval showing that FGF-
2-transduced NPCs invade the whole thickness of the slice, whereas control NPCs are mainly located at the surface of the slice.
Nuclear counterstainTo-Pro-3 (blue). (B) The majority of control NPCs remains at the surface of the cortical slice whereas FGF-2-
transduced NPCs invade the whole thickness of the slice (P_0.001, Chi-square test). CTRL=control GFP-vector transduction, FGF
vector=FGF-2-GFP vector transduction. Scale bar=20mm.
Fig. 4 FGF-2 transduction increases the dispersion and migration speed of NPCs in cortical slices after in vivo transplantation.
(A) Epifluorescence images of sagittal slices cut at P5 after in vivo transplantation at P3 showing that between DIV0 and DIV2, the
dispersion of FGF-2-transduced NPCs in the cortex is increased compared to controls. (B) Time-lapse sequence showing a control
NPC actively extending (arrow-head) and retracting processes while the soma remains stationary. (C) Time-lapse sequence showing
a FGF-2-transduced NPC migrating while switching from a bipolar to a multipolar morphology. Note the appearance of a transient lateral
process (arrow). (D) Time-lapse sequence showing the migration and division of a FGF-2-transduced NPC.The migrating cell (arrows)
divides into two daughter cells (arrow-heads) that continue to migrate. (E) Graph showing a shift in the migration speed of FGF-2-
transduced NPCs compared to controls (P_0.001, Chi-square test). (F) Representative migration tracks of 25 control NPCs compared
to 25 FGF-2-transduced NPCs during a time-lapse sequence of 130min.Only a small fraction of control NPCs migrate distances higher
than 20mm in contrast to the majority of FGF-2-transduced NPCs.The starting point for each cell is the interaction between the X
and Yaxes (0,0). CTRL=control GFP-vector transduction, FGF vector=FGF-2-GFP vector transduction. Scale bar=100mm in A,
20mm in B ^D.
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Fig. 5 FGF-2 transduction increases the dispersion of NPCs and maintains their proliferative immature phenotype after in vivo
transplantation. (A) Epifluorescent image showing the site of transplantation in the cortex (left). (B) Dispersion of grafted control NPCs
(middle) and FGF-2-transduced NPCs (right) 2 weeks after transplantation. (C) Epifluorescent images showing the increased dispersion
of grafted FGF-2-transduced NPCs compared to control tomato-labelled NPCs 8 days after transplantation. (D) Increased dispersion of
FGF-2-transduced NPCs compared to tomato-labelled NPCs 8 days after transplantation (P_0.001, Chi-square test.) (E) Confocal images
showing a higher fraction of BrdU positive FGF-2-transduced NPCs (right) compared to control NPCs (left) 1week after transplantation.
(F) FGF-2-transduced NPCs expressing the immature neural marker nestin 2 weeks after transplantation. (G) One week after
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percentage progressively decreased (Fig. 5I). Taken together,
these results indicate that the proliferative and migratory
properties of FGF-2-transduced NPCs as well as their
immature phenotype is transient and that the loss of these
properties is strongly correlated with a gradual down-
regulation of FGF-2 production.
FGF-2 transduction increases the pool of
grafted olfactory bulb neurons
To test the behaviour of FGF-2-transduced NPCs in a
physiological neurogenic system, we transplanted tomato-
labelled control NPCs and FGF-2-transduced NPCs in the
P0 anterior subventricular zone (SVZ). Brains analysed
at different time points after transplantation revealed that
both FGF-2-transduced NPCs and control NPCs were
found in the SVZ, along the rostral migratory stream and
in the olfactory bulb where they had differentiated into
immature neurons expressing doublecortin (Fig. 6A1,A2
and C). Six weeks after transplantation, numerous GFP
positive neurons with well-developed processes could be
observed in the olfactory bulb. These cells extended typical
dendrites, expressed the more mature neuronal marker
NeuN and displayed the characteristic morphology of
granular interneurons (Fig. 6D). Quantification of the
ratio of GFP versus tomato-labelled neurons at 4 weeks in
the olfactory bulb revealed that neurons derived from
FGF-2-transduced NPCs were 4 times more abundant than
control neurons indicating that FGF-2 transduction could
efficiently increase the amount of transplanted neurons in
the olfactory bulb (Fig. 6B). To further confirm that the
loss of an immature phenotype strongly correlates with
a gradual down-regulation of the levels of FGF-2, we
quantified the amount of GFP positive cells immunoreac-
tive for FGF-2 in the rostral migratory stream and in the
olfactory bulb 1 month after transplantation. We found that
only a very small fraction of FGF-2-transduced neuroblasts
in the rostral migratory stream (1.8 0.6% mean SEM)
and FGF-2-transduced neurons in the olfactory bulb
(4.4 0.7% mean SEM) continued to express FGF-2,
indicating that the loss of an immature phenotype is
strongly correlated with FGF-2 down-regulation.
Transplantation of FGF-2-transduced NPCs
after neonatal ischaemia
To study the behaviour of FGF-2-transduced NPCs in an
ischaemic environment, we used an animal model of
neonatal ischaemia. In this model, rats at postnatal day 3
undergo right carotid artery coagulation followed by 6%
hypoxia for 30 min. This moderate hypoxic-ischaemic
injury leads to selective neuronal loss in the infragranular
layers of the somatosensory cortex (Sizonenko et al., 2005).
After grafting NPCs at the base of the cortex, close to the
ischaemic sites (Fig. 7A), the migration pattern of labelled
cells was determined in fixed tissues at different intervals.
Two weeks after transplantation, we observed that both
control and FGF-2-transduced NPCs, had survived,
migrated out of the injection site and dispersed in a
region that included the infragranular ischaemic cortex and
the margin between the cortex and the corpus callosum
(Fig. 7A). When comparing the two groups, we observed
that FGF-2 transduction significantly increased the number
of FGF-2-transduced cells located in the ischaemic regions
compared to control cells. Quantification of the ratio of
GFP versus tomato-labelled cells at 2 weeks in the ischaemic
cortex revealed that FGF-2-transduced NPCs were 2.4 times
more abundant than control NPCs indicating that
FGF-2 transduction could efficiently increase the pool of
grafted NPCs in the ischaemic cortex (Fig. 7I). At this
survival time point, only 31.0 4.4% (mean SEM) of
FGF-2-transduced NPCs still expressed FGF-2, indicating
that FGF-2 down-regulation also occurred in an ischaemic
environment and was correlated with neural differentiation.
The differentiation process was similar in both the control
condition and after FGF-2 transduction (Fig. 7J). A large
fraction of grafted cells remained nestin positive (Fig. 6D),
while a proportion of them were found expressing the
astrocytic marker GFAP or the oligodendrocytic marker
NG2 (Fig. 6J). Most importantly 50% of grafted cells
expressed the immature neuronal marker doublecortin
(DCX) (Fig. 7B,C and J). Quantification revealed that the
number of grafted immature doublecortin positive neurons
was significantly increased after FGF-2 transduction
(447.1 96.6 (mean SEM) cells/mm2) compared to the
control condition (135.3 19.4 (mean SEM) cells/mm2)
(P50.05, t-test), indicating that the ischaemic environment
could promote neurogenesis, in contrast to the non-
ischaemic cortex where very few neurons were observed.
In the ischaemic lesion, grafted cells could differentiate
into neurons expressing the g-aminobutyric acid (GABA)
synthesizing enzyme glutamic acid decarboxylase 67
(GAD67) (Fig. 7F) and a later survival time points the
calcium-binding protein calretinin (Fig. 7G). No FGF-
2-transduced cells were immunoreactive for calbindin or
parvalbumin. Some FGF-2-transduced cells had acquired
a more complex neuronal morphology and expressed the
neuronal marker NeuN (Fig. 7H). These results indicate
transplantation the percentage of BrdU positive NPCs is increased after FGF-2-transduction compared to controls. Two weeks after
transplantation, the majority of FGF-2-transduced NPCs remain nestin positive compared to controls, whereas the majority of control
NPCs differentiate into NG2 positive cells. (P_0.005, t-test). (H) Confocal images showing cytoplasmic and nuclear FGF-2 immuno-
reactivity in FGF-2-transduced NPCs (arrows) and nuclear FGF-2 immunoreactivity in resident cells (arrow-head). (I) Graph showing
a time-dependent FGF-2 down-regulation in grafted FGF-2-transduced NPCs.CTRL=control GFP-vector transduction,
CTRL-TOM=control tomato-vector transduction, FGF vector=FGF-2-GFP vector transduction. Scale bar=200mm for epifluorescence
images and 20mm for confocal images.
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that an ischaemic environment can dramatically change the
phenotypic fate of both control and FGF-2-transduced
NPCs and that FGF-2 over-expression increases the pool
of NPCs available for brain repair.
Discussion
The identification of molecular signals that could enhance
the capacity of grafted NPCs to invade an injured area in
the brain is of key importance for neural cell replacement
Fig. 6 FGF-2-transduction increases the pool of grafted neurons in the olfactory bulb. (A1) Epifluorescent image of a sagittal section
showing FGF-2-transduced NPCs and tomato-labelled NPCs migrating along the rostral migratory stream1month after transplantation in
the SVZ. (A2) Confocal images showing that both control and FGF-2-transduced neuroblasts do not express FGF-2. (B) The proportion of
GFP-FGF-2-transduced neurons is significantly increased compared to control tomato-labelled neurons in the olfactory bulb 1month after
transplantation (P_0.001, t-test). (C) FGF-2-transduced NPC (arrow-head) which has reached the granule cell layer of the olfactory bulb
and is positive for DCX1week after transplantation. (D) FGF-2-transduced neuron extending a dendritic arbourization in the olfactory
bulb 6 weeks after transplantation. Insert showing that the cell is immunoreactive for NeuN. (E) Epifluorescent image at lowmagnification
showing a higher proportion of FGF-2-transduced neurons compared to tomato-labelled neurons in the olfactory bulb 1month
after transplantation. CTRL-TOM=control tomato-vector transduction,GFP=FGF-2-GFP vector transduction, Hst=Hoechst.
Scale bar=100mm for epifluorescence images and 20mm for confocal images.
Fig. 7 FGF-2 transduction increases the pool of grafted neural progenitors in the ischaemic cortex. (A) Epifluorescent composite images of
a coronal section showing an ischaemic cortex 1month after transplantation of FGF-2-transduced NPCs. Note the injection site (arrow)
and the large dispersion of FGF-2-transduced NPCs at the margin between the corpus callosum and the ischaemic infragranular layers
(arrow-heads). (B) Confocal images showing a pool of FGF-2-transduced NPCs positive for the immature neuronal marker doublecortin
(DCX). Insert showing an FGF-2-transduced neuron positive for NeuN and DCX. (C) FGF-2-transduced cell extending a DCX immunor-
eactive process towards the ischaemic cortex. (D) FGF-2-transduced NPCs expressing nestin. (E) FGF-2-transduced NPCs form a larger
pool compared to co-transplanted tomato-labelled NPCs 8 days after transplantation. (F) FGF-2-transduced NPC expressing the GABA
synthesizing enzyme GAD67 2 weeks after transplantation (G) FGF-2-transduced NPC expressing the calcium-binding protein calretinin
6 weeks after transplantation. (H) FGF-2-transduced cell expressing NeuN and displaying a more mature neuronal morphology 4 weeks
after transplantation. (I) The proportion of FGF-2-transduced NPCs is significantly increased compared to tomato-labelled NPCs 2 weeks
after transplantation (P_0.001, t-test). (J) Both control and FGF-2-transduced NPCs differentiate into GFAP positive cells, NG2 positive
cells and immature neurons positive for doublecortin. A large proportion of grafted NPCs remain nestin positive. CTRL-TOM=control
tomato-vector transduction,GFP=FGF-2-GFP vector transduction. Scale bar=200mm for epifluorescence images and 20mm for
confocal images.
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and structural repair. Here we developed a novel system
allowing the over-expression of FGF-2 in NPCs and studied
its effects on several cellular functions after transplantation
into the early postnatal rat cortex. We provide direct
evidence for the first time that FGF-2 over-expression not
only enhances the proliferative activity, as has been shown
previously, but that it also dramatically enhances the
migratory properties of grafted NPCs. When transplanted
into a neurogenic region such as the SVZ, FGF-2-expressing
NPCs gave rise to a significantly increased pool of new
interneurons in the olfactory bulb, without altering their
differentiation potential. A striking observation of the
present study is that differentiation of progenitor cells
into immature neurons was systematically correlated with
a down-regulation of the FGF-2 transgene. Finally and
most importantly, we show that after transplantation
into a neonatal ischaemic cortex, FGF-2 over-expressing
NPCs efficiently invade the injured cortex and generate
an increased pool of immature neurons available for brain
repair. These results reveal an important role for FGF-2
in regulating NPCs functions when interacting with the
host tissue and offer a potential strategy to generate a
robust source of migrating neural progenitors for repairing
a neonatal ischaemic cortex.
Using a lentiviral gene transfer system, we successfully
over-expressed FGF-2 in NPCs and showed that this
technology could be a reliable and non-toxic tool to
genetically engineer primary cultures of NPCs. FACS
analysis allowed us to estimate the number of copies that
transduced NPCs had incorporated in their genome.
According to our calculations, using lentiviral vector
doses of 1.5 105 TU/ml, 2–3 copies of the FGF-2 lentiviral
vector were incorporated in the genome. With this range
of copy number, FGF-2 transduction was able to produce
a 10-fold increase in the amount of FGF-2 secreted in
the culture medium. Our data suggest that in vitro this
relatively low amount of secreted FGF-2 had a potent
biological effect since it could maintain the proliferation of
NPCs in culture at a level equivalent to that measured after
the exogenous addition of FGF-2 at a dose of 20 ng/ml.
Noteworthy that control NPCs secrete low but detect-
able amounts of FGF-2 into culture media hence confirm-
ing previous reports (Maric et al., 2003) and supporting
the concept that autocrine/paracrine axes of FGF signalling
might regulate biological properties of progenitor cells.
Previous studies demonstrated that FGF-2 signalling is
a potent regulator of mammalian neurogenesis (Ghosh and
Greenberg, 1995; Temple and Qian, 1995; Palmer et al.,
1999; Ford-Perriss et al., 2001). FGF-2 appears to be a
major determinant in maintaining proliferative and undif-
ferentiated populations of NPCs in vitro (Maric et al., 2003)
and in neurogenic zones such as the SVZ in vivo
(Zheng et al., 2004). It has also been reported to be critical
in the reprogramming of primordial germ cells into
pluripotent stem cells (Durcova-Hills et al., 2006) and in
maintaining pluripotency in human embryonic stem cells
(Amit et al., 2000). However, its role in regulating dynamic
interactions of grafted NPCs with the recipient host tissue
was unknown. This is a critical issue since NPCs rapidly
differentiate after grafting into postnatal brain tissue.
Using a lentiviral-based approach, we demonstrated that
FGF-2 over-expression in grafted NPCs was sufficient
to maintain their immature phenotype as well as their
proliferative and migratory properties in a tissue context.
In striking contrast, grafted control cells rapidly lost their
migratory and proliferative properties as well as their
immature phenotype while differentiating into glial cells.
Co-transplantation experiments with tomato-labelled
control NPCs mixed with GFP-labelled FGF-2 over-
expressing NPCs, revealed that the presence of FGF-
2-transduced cells was not sufficient to confer increased
migratory properties to control cells. Thus, cross-talk
through paracrine signalling of FGF-2 between NPCs may
not be sufficient to maintain an undifferentiated and
migratory phenotype and we speculate that an autocrine
signalling loop of FGF-2 might underlie the observed
biological effects of FGF-2 transduction. The expression of
FGF receptor 1 and FGF receptor 2 at the mRNA and
protein level in FGF-2-transduced NPCs further support the
hypothesis that over-secretion of FGF-2 in the extracellular
compartment could maintain the biological properties of
FGF-2-transduced NPCs by signalling through specific
FGF-2 receptors. In addition to this mechanism, it remains
possible that the secreted 18 kDa FGF-2 isoform after
binding to its receptors could be internalized and reach
the nucleus where it could regulate cellular processes in
an intracrine fashion (Sorensen et al., 2006).
We systematically observed that the migratory and
proliferative properties of FGF-2-transduced NPCs were
transient and were lost at longer survival time points. We
never detected tumour formation and the dispersion of
grafted cells was limited to a few hundred micrometres
from the injection site. Cell fusion events have been
reported after transplantation of stem cells in various
organs. However, several arguments indicate that in our
system grafted NPCs do not appear to fuse to resident cells.
Using time-lapse imaging, we were able to directly monitor
the behaviour of GFP-labelled NPCs after engraftment in
various brain regions. No cell fusion events were detected in
time-lapse movies monitoring the migration of NPCs in the
cortex, in the rostral migratory stream and in the olfactory
bulb. Furthermore, no evidence for multinucleated cells was
detected after confocal imaging of hundreds of grafted
NPCs in various brain regions. Although we cannot totally
exclude the possibility that rare cell fusion events could
occur after transplantation, these rare events would not
modify the results obtained in this study.
By tracking the level of FGF-2 expression in grafted cells
at different survival time points and in different transplan-
tation sites, we found that the loss of the proliferative and
migratory properties of FGF-2 over-expressing NPCs
was strongly correlated with a spontaneous and gradual
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down-regulation of FGF-2 production. Furthermore, we
found that FGF-2 down-regulation was also strongly
correlated with the appearance of grafted cells capable of
differentiating into a wide range of glial and neuronal cells
displaying normal morphologies and expressing standard
markers of differentiation. Several mechanisms could
account for the observed FGF-2 down-regulation, such as
decreased transcription levels, increased mRNA instability,
decreased mRNA translation and increased protein degra-
dation. Interestingly, the majority of FGF-2-transduced
NPCs grafted in the anterior SVZ continued to express
FGF-2 1 month after transplantation (unpublished data),
suggesting that in vivo FGF-2 down-regulation may occur
in a region-dependent fashion.
The combination of confocal video time-lapse micro-
scopy and cortical slice preparations allowed us to directly
observe the migration of FGF-2-transduced NPCs in a 3D
tissue context. Imaging of FGF-2-transduced NPCs in
cortical slices revealed an important pool of individually
migrating NPCs. This pool of migrating cells was
significantly reduced but not absent in the control situation,
indicating that FGF-2 transduction increases the fraction of
migrating cells but does not induce a mode of migration
which is absent in the control situation. These observations
are consistent with previous reports showing that FGF
signalling stimulates the migration of astrocytes (Holland
and Varmus, 1998; Sorensen et al., 2006), myoblasts (Allen
et al., 2003), oligodendrocyte progenitors (Simpson and
Armstrong, 1999) and germ cells (Takeuchi et al., 2005).
Interestingly mitosis could be directly observed online
after a phase of migration in a small fraction of FGF-2-
transduced NPCs and more rarely with control NPCs.
These time-lapse observations indicate that immature NPCs
are able to migrate and divide in a complex 3D structure.
Post hoc confocal Z-stacks taken throughout the cortical
slice demonstrated that FGF-2-transduced NPCs had the
ability to migrate inside the cortical tissue, whereas control
NPCs mainly remained on the surface of the slice, further
demonstrating the enhanced invasive migratory properties
of FGF-2-transduced NPCs. The molecular mechanisms of
this effect remain to be determined. One of the possibilities
is that FGF-2 facilitates migration through stimulating the
secretion of matrix degrading enzymes such as MMP 2 and
9 (Tsuboi et al., 1990; Kenagy et al., 1997).
Overall our results indicate that the over-expression
of FGF-2 in NPCs prior to transplantation could be of
considerable interest to generate a larger pool of prolif-
erative and migrating neural progenitor cells available for
brain repair (creation of a ‘launch pad’ in situ).
Furthermore, we show that FGF-2-transduced NPCs can
be recruited towards sites of brain injury where they
generate dense clusters of immature neurons. The addition
of a large pool of immature neurons in a damaged neonatal
cortex represents a promising strategy to achieve efficient
neuronal replacement. Additional studies are needed to
determine if this strategy could lead to functional
improvements in transplanted rats. Furthermore, the
behaviour of FGF-2-transduced NPCs in an adult ischaemic
cortex remains to be determined. Finally, it remains a long-
term goal to understand the molecular mechanisms that
regulate the survival and integration of immature neuronal
precursors in a damaged cortex.
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Supplementary material is available at Brain online.
Acknowledgements
We wish to thank S. Chliate and C. Saadi for technical
assistance. This work was supported by the Swiss National
Foundation grant 31-64030.00, the Eagle Foundation and
by the European Community Grant Promemoria
No. 512012-2005 to Jozsef Z. Kiss.
References
Allen DL, Teitelbaum DH, Kurachi K. Growth factor stimulation of matrix
metalloproteinase expression and myoblast migration and invasion
in vitro. Am J Physiol Cell Physiol 2003; 284: C805–15.
Amit M, Carpenter MK, Inokuma MS, Chiu CP, Harris CP, Waknitz MA,
et al. Clonally derived human embryonic stem cell lines maintain
pluripotency and proliferative potential for prolonged periods of
culture. Dev Biol 2000; 227: 271–8.
Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O. Neuronal
replacement from endogenous precursors in the adult brain after
stroke. Nat Med 2002; 8: 963–70.
Bjorklund A, Lindvall O. Self-repair in the brain. Nature 2000; 405:
892–3, 895.
Durcova-Hills G, Adams IR, Barton SC, Surani MA, McLaren A. The role
of exogenous fibroblast growth factor-2 on the reprogramming of
primordial germ cells into pluripotent stem cells. Stem Cells 2006; 24:
1441–9.
Ford-Perriss M, Abud H, Murphy M. Fibroblast growth factors in the
developing central nervous system. Clin Exp Pharmacol Physiol 2001;
28: 493–503.
Ghosh A, Greenberg ME. Distinct roles for bFGF and NT-3 in the
regulation of cortical neurogenesis. Neuron 1995; 15: 89–103.
Holland EC, Varmus HE. Basic fibroblast growth factor induces cell
migration and proliferation after glia-specific gene transfer in mice.
Proc Natl Acad Sci USA 1998; 95: 1218–23.
Jiang W, Gu W, Brannstrom T, Rosqvist R, Wester P. Cortical
neurogenesis in adult rats after transient middle cerebral artery
occlusion. Stroke 2001; 32: 1201–7.
Jin K, Sun Y, Xie L, Peel A, Mao XO, Batteur S, et al. Directed migration
of neuronal precursors into the ischemic cerebral cortex and striatum.
Mol Cell Neurosci 2003; 24: 171–89.
Kenagy RD, Hart CE, Stetler-Stevenson WG, Clowes AW. Primate smooth
muscle cell migration from aortic explants is mediated by endogenous
platelet-derived growth factor and basic fibroblast growth factor acting
through matrix metalloproteinases 2 and 9. Circulation 1997; 96:
3555–60.
Kuhn HG, Winkler J, Kempermann G, Thal LJ, Gage FH. Epidermal
growth factor and fibroblast growth factor-2 have different effects on
neural progenitors in the adult rat brain. J Neurosci 1997; 17: 5820–9.
Lim DA, Tramontin AD, Trevejo JM, Herrera DG, Garcia-Verdugo JM,
Alvarez-Buylla A. Noggin antagonizes BMP signaling to create a niche
for adult neurogenesis. Neuron 2000; 28: 713–26.
Magavi SS, Leavitt BR, Macklis JD. Induction of neurogenesis in the
neocortex of adult mice. Nature 2000; 405: 951–5.
Expression of FGF-2 in neural progenitors Brain (2007), 130, 2962^2976 2975
Maric D, Maric I, Chang YH, Barker JL. Prospective cell sorting of
embryonic rat neural stem cells and neuronal and glial progenitors
reveals selective effects of basic fibroblast growth factor and epidermal
growth factor on self-renewal and differentiation. J Neurosci 2003; 23:
240–51.
Nakatomi H, Kuriu T, Okabe S, Yamamoto S, Hatano O, Kawahara N,
et al. Regeneration of hippocampal pyramidal neurons after ischemic
brain injury by recruitment of endogenous neural progenitors. Cell
2002; 110: 429–41.
Palmer TD, Markakis EA, Willhoite AR, Safar F, Gage FH. Fibroblast
growth factor-2 activates a latent neurogenic program in neural stem
cells from diverse regions of the adult CNS. J Neurosci 1999; 19:
8487–97.
Rinsch C, Quinodoz P, Pittet B, Alizadeh N, Baetens D, Montandon D,
et al. Delivery of FGF-2 but not VEGF by encapsulated genetically
engineered myoblasts improves survival and vascularization in a model
of acute skin flap ischemia. Gene Ther 2001; 8: 523–33.
Shaner NC, Campbell RE, Steinbach PA, Giepmans BN, Palmer AE,
Tsien RY. Improved monomeric red, orange and yellow fluorescent
proteins derived from Discosoma sp. red fluorescent protein. Nat
Biotechnol 2004; 22: 1567–72.
Simpson PB, Armstrong RC. Intracellular signals and cytoskeletal elements
involved in oligodendrocyte progenitor migration. Glia 1999; 26: 22–35.
Sizonenko SV, Kiss JZ, Inder T, Gluckman PD, Williams CE. Distinctive
neuropathologic alterations in the deep layers of the parietal cortex after
moderate ischemic-hypoxic injury in the P3 immature rat brain. Pediatr
Res 2005; 57: 865–72.
Sizonenko SV, Sirimanne E, Mayall Y, Gluckman PD, Inder T, Williams C.
Selective cortical alteration after hypoxic-ischemic injury in the very
immature rat brain. Pediatr Res 2003; 54: 263–9.
Sorensen V, Nilsen T, Wiedlocha A. Functional diversity of FGF-2
isoforms by intracellular sorting. Bioessays 2006; 28: 504–14.
Takeuchi Y, Molyneaux K, Runyan C, Schaible K, Wylie C. The roles of
FGF signaling in germ cell migration in the mouse. Development 2005;
132: 5399–409.
Temple S, Qian X. bFGF, neurotrophins, and the control or cortical
neurogenesis. Neuron 1995; 15: 249–52.
Tsuboi R, Sato Y, Rifkin DB. Correlation of cell migration, cell invasion,
receptor number, proteinase production, and basic fibroblast growth
factor levels in endothelial cells. J Cell Biol 1990; 110: 511–7.
Zhang H, Vutskits L, Pepper MS, Kiss JZ. VEGF is a chemoattractant
for FGF-2-stimulated neural progenitors. J Cell Biol 2003; 163:
1375–84.
Zheng W, Nowakowski RS, Vaccarino FM. Fibroblast growth factor 2
is required for maintaining the neural stem cell pool in the mouse brain
subventricular zone. Dev Neurosci 2004; 26: 181–96.
2976 Brain (2007), 130, 2962^2976 A.G. Dayer et al.
